帕金森病患者皮质脑回化与影像及血清生物标志物的关联
研究纳入113例新发帕金森病患者和55名健康对照的纵向数据及两个横断面数据集,发现患者皮质脑回化指数和白质各向异性分数在1年内加速下降并在4年随访时进一步降低,且与白质微结构、纹状体多巴胺可用性及血清神经丝轻链水平相关。
要点
- 新发帕金森病患者皮质脑回化指数较健康对照加速下降,4年随访进一步降低。
- 皮质脑回化指数与白质各向异性分数、纹状体结合比相关,与覆盖皮质厚度无关。
- 皮质脑回化指数和白质各向异性分数均与血清神经丝轻链水平相关,与脑脊液α-突触核蛋白无关。
核心结论
- 帕金森病患者存在进行性皮质脑回化减少,且与白质微结构、纹状体多巴胺可用性及血清神经丝轻链水平密切相关。
- 这些发现可能为帕金森病进展提供生物标志物,并提示早期干预的潜在通路。
研究设计与样本
- 研究包含一个纵向数据集(基线T0、1年T1、4年T4随访)和两个横断面数据集。
- 纵向数据集纳入113例新发帕金森病患者和55名健康对照;横断面数据集纳入116例相对更进展的帕金森病患者和85名健康对照。
- 采用T1加权MRI计算局部脑回化指数,弥散加权MRI计算各向异性分数,123Ioflupane SPECT测量纹状体结合比,并检测血清神经丝轻链和脑脊液α-突触核蛋白水平。
主要发现
- 与健康对照相比,新发帕金森病患者在1年期间局部脑回化指数和各向异性分数加速下降,4年随访时进一步降低。
- 在帕金森病患者中,三个时间点的局部脑回化指数均与各向异性分数相关(T0 p=0.002,T1 p=0.0214,T4 p=0.0037),与纹状体结合比相关(T0 p=0.0095,T1 p=0.0035,T4 p=0.0096),但与覆盖皮质厚度无关。
- 在帕金森病患者中,局部脑回化指数和各向异性分数均与血清神经丝轻链水平相关(局部脑回化指数:T0 p<0.0001,T1 p=0.0043;各向异性分数:T0 p<0.0001,T1 p=0.0001),但与脑脊液α-突触核蛋白水平无关。
- 在两个横断面数据集中,相对更进展的帕金森病患者表现出相似的局部脑回化指数和各向异性分数下降模式及两者关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Pathologic progression across the cortex is a key feature of Parkinson disease (PD). Cortical gyrification is a morphologic feature of human cerebral cortex that is tightly linked to the integrity of underlying axonal connectivity. Monitoring cortical gyrification reductions may provide a sensitive marker of progression through structural connectivity, preceding the progressive stages of PD pathology. We aimed to examine the progressive cortical gyrification reductions and their associations with overlying cortical thickness, white matter (WM) integrity, striatum dopamine availability, serum neurofilament light (NfL) chain, and CSF α-synuclein levels in PD. METHODS: This study included a longitudinal dataset with baseline (T0), 1-year (T1), and 4-year (T4) follow-ups and 2 cross-sectional datasets. Local gyrification index (LGI) was computed from T1-weighted MRI data to measure cortical gyrification. Fractional anisotropy (FA) was computed from diffusion-weighted MRI data to measure WM integrity. Striatal binding ratio (SBR) was measured from 123Ioflupane SPECT scans. Serum NfL and CSF α-synuclein levels were also measured. RESULTS: The longitudinal dataset included 113 patients with de novo PD and 55 healthy controls (HCs). The cross-sectional datasets included 116 patients with relatively more advanced PD and 85 HCs. Compared with HCs, patients with de novo PD showed accelerated LGI and FA reductions over 1-year period and a further decline at 4-year follow-up. Across the 3 time points, the LGI paralleled and correlated with FA (p = 0.002 at T0, p = 0.0214 at T1, and p = 0.0037 at T4) and SBR (p = 0.0095 at T0, p = 0.0035 at T1, and p = 0.0096 at T4) but not with overlying cortical thickness in patients with PD. Both LGI and FA correlated with serum NfL level (LGI: p < 0.0001 at T0, p = 0.0043 at T1; FA: p < 0.0001 at T0, p = 0.0001 at T1) but not with CSF α-synuclein level in patients with PD. In the 2 cross-sectional datasets, we revealed similar patterns of LGI and FA reductions and associations between LGI and FA in patients with more advanced PD. DISCUSSION: We demonstrated progressive reductions in cortical gyrification that were robustly associated with WM microstructure, striatum dopamine availability, and serum NfL level in PD. Our findings may contribute biomarkers for PD progression and potential pathways for early interventions of PD.
引用
- Zhang Y, Zhang Y, Mao C, et al. Association of Cortical Gyrification With Imaging and Serum Biomarkers in Patients With Parkinson Disease. Neurology. 2023. PMID: 37268433. doi:10.1212/WNL.0000000000207410
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。